Daily Treatment with Valganciclovir Reduces Immune Activation in HIV…
SUMMARY: Daily treatment with the anti-herpes drug valganciclovir for 8 weeks led to a significant reduction in CD8 T-cell immune activation in HIV positive people coinfected with cytomegalovirus , researchers reported at the 17th Conference on Retroviruses & Opportunistic Infections last month in San Francisco.
If you enjoyed this post, make sure you subscribe to my RSS feed!
